nodes	percent_of_prediction	percent_of_DWPC	metapath
MACITENTAN—EDNRB—myometrium—ovarian cancer	0.039	0.0897	CbGeAlD
MACITENTAN—EDNRA—myometrium—ovarian cancer	0.0323	0.0741	CbGeAlD
MACITENTAN—EDNRB—uterine cervix—ovarian cancer	0.0304	0.0698	CbGeAlD
MACITENTAN—EDNRB—decidua—ovarian cancer	0.0289	0.0665	CbGeAlD
MACITENTAN—EDNRB—endometrium—ovarian cancer	0.0275	0.0631	CbGeAlD
MACITENTAN—EDNRB—uterus—ovarian cancer	0.0253	0.0582	CbGeAlD
MACITENTAN—EDNRA—uterine cervix—ovarian cancer	0.0251	0.0577	CbGeAlD
MACITENTAN—EDNRA—decidua—ovarian cancer	0.0239	0.055	CbGeAlD
MACITENTAN—EDNRA—endometrium—ovarian cancer	0.0227	0.0522	CbGeAlD
MACITENTAN—CYP3A4—Topotecan—ovarian cancer	0.0224	0.354	CbGbCtD
MACITENTAN—EDNRA—uterus—ovarian cancer	0.0209	0.0481	CbGeAlD
MACITENTAN—EDNRB—female gonad—ovarian cancer	0.0207	0.0476	CbGeAlD
MACITENTAN—EDNRB—vagina—ovarian cancer	0.0206	0.0473	CbGeAlD
MACITENTAN—EDNRB—testis—ovarian cancer	0.0184	0.0422	CbGeAlD
MACITENTAN—EDNRA—female gonad—ovarian cancer	0.0171	0.0393	CbGeAlD
MACITENTAN—EDNRA—vagina—ovarian cancer	0.017	0.0391	CbGeAlD
MACITENTAN—Hepatotoxicity—Chlorambucil—ovarian cancer	0.0164	0.0597	CcSEcCtD
MACITENTAN—CYP3A4—Vinorelbine—ovarian cancer	0.0158	0.25	CbGbCtD
MACITENTAN—EDNRA—testis—ovarian cancer	0.0152	0.0349	CbGeAlD
MACITENTAN—Anaemia—Altretamine—ovarian cancer	0.0144	0.0524	CcSEcCtD
MACITENTAN—EDNRB—lymph node—ovarian cancer	0.0133	0.0306	CbGeAlD
MACITENTAN—CYP3A4—Paclitaxel—ovarian cancer	0.0111	0.175	CbGbCtD
MACITENTAN—EDNRA—lymph node—ovarian cancer	0.011	0.0253	CbGeAlD
MACITENTAN—Infection—Carboplatin—ovarian cancer	0.00871	0.0317	CcSEcCtD
MACITENTAN—ALB—testis—ovarian cancer	0.00805	0.0185	CbGeAlD
MACITENTAN—CYP3A4—Docetaxel—ovarian cancer	0.00803	0.127	CbGbCtD
MACITENTAN—CYP2C19—vagina—ovarian cancer	0.00726	0.0167	CbGeAlD
MACITENTAN—Hepatotoxicity—Docetaxel—ovarian cancer	0.00711	0.0259	CcSEcCtD
MACITENTAN—Infestation NOS—Topotecan—ovarian cancer	0.0063	0.0229	CcSEcCtD
MACITENTAN—Infestation—Topotecan—ovarian cancer	0.0063	0.0229	CcSEcCtD
MACITENTAN—Fluid retention—Paclitaxel—ovarian cancer	0.00615	0.0224	CcSEcCtD
MACITENTAN—CYP3A4—Doxorubicin—ovarian cancer	0.00599	0.0945	CbGbCtD
MACITENTAN—ALB—lymph node—ovarian cancer	0.00583	0.0134	CbGeAlD
MACITENTAN—Pharyngitis—Topotecan—ovarian cancer	0.00561	0.0204	CcSEcCtD
MACITENTAN—Infestation NOS—Vinorelbine—ovarian cancer	0.00539	0.0196	CcSEcCtD
MACITENTAN—Infestation—Vinorelbine—ovarian cancer	0.00539	0.0196	CcSEcCtD
MACITENTAN—Fluid retention—Docetaxel—ovarian cancer	0.00521	0.019	CcSEcCtD
MACITENTAN—Angiopathy—Topotecan—ovarian cancer	0.00513	0.0187	CcSEcCtD
MACITENTAN—Anaemia—Chlorambucil—ovarian cancer	0.00511	0.0186	CcSEcCtD
MACITENTAN—CYP3A4—female reproductive system—ovarian cancer	0.00475	0.0109	CbGeAlD
MACITENTAN—Anaemia—Topotecan—ovarian cancer	0.00455	0.0166	CcSEcCtD
MACITENTAN—Infection—Chlorambucil—ovarian cancer	0.00448	0.0163	CcSEcCtD
MACITENTAN—Anaemia—Melphalan—ovarian cancer	0.00445	0.0162	CcSEcCtD
MACITENTAN—Angiopathy—Vinorelbine—ovarian cancer	0.00439	0.016	CcSEcCtD
MACITENTAN—Nasopharyngitis—Paclitaxel—ovarian cancer	0.0042	0.0153	CcSEcCtD
MACITENTAN—Influenza—Paclitaxel—ovarian cancer	0.00406	0.0148	CcSEcCtD
MACITENTAN—Infection—Topotecan—ovarian cancer	0.00399	0.0145	CcSEcCtD
MACITENTAN—Nervous system disorder—Topotecan—ovarian cancer	0.00394	0.0143	CcSEcCtD
MACITENTAN—Oedema—Melphalan—ovarian cancer	0.00393	0.0143	CcSEcCtD
MACITENTAN—Bronchitis—Paclitaxel—ovarian cancer	0.00391	0.0142	CcSEcCtD
MACITENTAN—Infection—Melphalan—ovarian cancer	0.00391	0.0142	CcSEcCtD
MACITENTAN—Anaemia—Vinorelbine—ovarian cancer	0.00389	0.0142	CcSEcCtD
MACITENTAN—Hypotension—Melphalan—ovarian cancer	0.00367	0.0134	CcSEcCtD
MACITENTAN—Infestation NOS—Paclitaxel—ovarian cancer	0.00362	0.0132	CcSEcCtD
MACITENTAN—Infestation—Paclitaxel—ovarian cancer	0.00362	0.0132	CcSEcCtD
MACITENTAN—Nasopharyngitis—Docetaxel—ovarian cancer	0.00356	0.013	CcSEcCtD
MACITENTAN—Urinary tract infection—Paclitaxel—ovarian cancer	0.00352	0.0128	CcSEcCtD
MACITENTAN—Fluid retention—Epirubicin—ovarian cancer	0.00351	0.0128	CcSEcCtD
MACITENTAN—Infection—Vinorelbine—ovarian cancer	0.00341	0.0124	CcSEcCtD
MACITENTAN—Nervous system disorder—Vinorelbine—ovarian cancer	0.00337	0.0123	CcSEcCtD
MACITENTAN—Fluid retention—Doxorubicin—ovarian cancer	0.00325	0.0118	CcSEcCtD
MACITENTAN—Pharyngitis—Paclitaxel—ovarian cancer	0.00323	0.0118	CcSEcCtD
MACITENTAN—Hypotension—Vinorelbine—ovarian cancer	0.00321	0.0117	CcSEcCtD
MACITENTAN—Infestation NOS—Docetaxel—ovarian cancer	0.00307	0.0112	CcSEcCtD
MACITENTAN—Infestation—Docetaxel—ovarian cancer	0.00307	0.0112	CcSEcCtD
MACITENTAN—Angiopathy—Paclitaxel—ovarian cancer	0.00295	0.0108	CcSEcCtD
MACITENTAN—Pharyngitis—Docetaxel—ovarian cancer	0.00274	0.00997	CcSEcCtD
MACITENTAN—Anaemia—Paclitaxel—ovarian cancer	0.00262	0.00953	CcSEcCtD
MACITENTAN—Headache—Topotecan—ovarian cancer	0.00252	0.00917	CcSEcCtD
MACITENTAN—Angiopathy—Docetaxel—ovarian cancer	0.0025	0.00911	CcSEcCtD
MACITENTAN—Nasopharyngitis—Epirubicin—ovarian cancer	0.0024	0.00876	CcSEcCtD
MACITENTAN—Influenza—Epirubicin—ovarian cancer	0.00232	0.00846	CcSEcCtD
MACITENTAN—Oedema—Paclitaxel—ovarian cancer	0.00231	0.00842	CcSEcCtD
MACITENTAN—Infection—Paclitaxel—ovarian cancer	0.0023	0.00836	CcSEcCtD
MACITENTAN—Nervous system disorder—Paclitaxel—ovarian cancer	0.00227	0.00826	CcSEcCtD
MACITENTAN—Bronchitis—Epirubicin—ovarian cancer	0.00223	0.00814	CcSEcCtD
MACITENTAN—Nasopharyngitis—Doxorubicin—ovarian cancer	0.00222	0.0081	CcSEcCtD
MACITENTAN—Anaemia—Docetaxel—ovarian cancer	0.00222	0.00808	CcSEcCtD
MACITENTAN—Hypotension—Paclitaxel—ovarian cancer	0.00216	0.00787	CcSEcCtD
MACITENTAN—Headache—Vinorelbine—ovarian cancer	0.00215	0.00784	CcSEcCtD
MACITENTAN—Influenza—Doxorubicin—ovarian cancer	0.00215	0.00783	CcSEcCtD
MACITENTAN—Infestation NOS—Epirubicin—ovarian cancer	0.00207	0.00755	CcSEcCtD
MACITENTAN—Infestation—Epirubicin—ovarian cancer	0.00207	0.00755	CcSEcCtD
MACITENTAN—Bronchitis—Doxorubicin—ovarian cancer	0.00207	0.00753	CcSEcCtD
MACITENTAN—Urinary tract infection—Epirubicin—ovarian cancer	0.00201	0.00734	CcSEcCtD
MACITENTAN—Oedema—Docetaxel—ovarian cancer	0.00196	0.00714	CcSEcCtD
MACITENTAN—Infection—Docetaxel—ovarian cancer	0.00195	0.00709	CcSEcCtD
MACITENTAN—Nervous system disorder—Docetaxel—ovarian cancer	0.00192	0.007	CcSEcCtD
MACITENTAN—Infestation—Doxorubicin—ovarian cancer	0.00192	0.00698	CcSEcCtD
MACITENTAN—Infestation NOS—Doxorubicin—ovarian cancer	0.00192	0.00698	CcSEcCtD
MACITENTAN—Urinary tract infection—Doxorubicin—ovarian cancer	0.00186	0.00679	CcSEcCtD
MACITENTAN—Pharyngitis—Epirubicin—ovarian cancer	0.00185	0.00672	CcSEcCtD
MACITENTAN—Hypotension—Docetaxel—ovarian cancer	0.00183	0.00667	CcSEcCtD
MACITENTAN—Pharyngitis—Doxorubicin—ovarian cancer	0.00171	0.00622	CcSEcCtD
MACITENTAN—Angiopathy—Epirubicin—ovarian cancer	0.00169	0.00615	CcSEcCtD
MACITENTAN—Angiopathy—Doxorubicin—ovarian cancer	0.00156	0.00569	CcSEcCtD
MACITENTAN—Anaemia—Epirubicin—ovarian cancer	0.0015	0.00545	CcSEcCtD
MACITENTAN—Headache—Paclitaxel—ovarian cancer	0.00145	0.00527	CcSEcCtD
MACITENTAN—Anaemia—Doxorubicin—ovarian cancer	0.00138	0.00504	CcSEcCtD
MACITENTAN—Oedema—Epirubicin—ovarian cancer	0.00132	0.00481	CcSEcCtD
MACITENTAN—Infection—Epirubicin—ovarian cancer	0.00131	0.00478	CcSEcCtD
MACITENTAN—Nervous system disorder—Epirubicin—ovarian cancer	0.0013	0.00472	CcSEcCtD
MACITENTAN—Hypotension—Epirubicin—ovarian cancer	0.00123	0.0045	CcSEcCtD
MACITENTAN—Headache—Docetaxel—ovarian cancer	0.00123	0.00447	CcSEcCtD
MACITENTAN—Oedema—Doxorubicin—ovarian cancer	0.00122	0.00445	CcSEcCtD
MACITENTAN—Infection—Doxorubicin—ovarian cancer	0.00121	0.00442	CcSEcCtD
MACITENTAN—Nervous system disorder—Doxorubicin—ovarian cancer	0.0012	0.00437	CcSEcCtD
MACITENTAN—Hypotension—Doxorubicin—ovarian cancer	0.00114	0.00416	CcSEcCtD
MACITENTAN—Headache—Epirubicin—ovarian cancer	0.000827	0.00302	CcSEcCtD
MACITENTAN—Headache—Doxorubicin—ovarian cancer	0.000766	0.00279	CcSEcCtD
MACITENTAN—EDNRB—Signaling Pathways—SMARCA4—ovarian cancer	0.00048	0.00212	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—RAD51C—ovarian cancer	0.000476	0.0021	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—ovarian cancer	0.000472	0.00208	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—EREG—ovarian cancer	0.000468	0.00207	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—IL2—ovarian cancer	0.000441	0.00195	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—CYP1B1—ovarian cancer	0.000441	0.00194	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PGR—ovarian cancer	0.000439	0.00194	CbGpPWpGaD
MACITENTAN—CYP2C19—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000435	0.00192	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—ovarian cancer	0.000433	0.00191	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000413	0.00182	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PARP1—ovarian cancer	0.000408	0.0018	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—HDAC6—ovarian cancer	0.000407	0.00179	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—PPP2R1A—ovarian cancer	0.000401	0.00177	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ovarian cancer	0.000401	0.00177	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—IL6ST—ovarian cancer	0.00039	0.00172	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CXCL8—ovarian cancer	0.000385	0.0017	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ovarian cancer	0.000384	0.00169	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000383	0.00169	CbGpPWpGaD
MACITENTAN—ALB—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.000381	0.00168	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000379	0.00167	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—PIK3CG—ovarian cancer	0.000375	0.00165	CbGpPWpGaD
MACITENTAN—ALB—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000368	0.00162	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000367	0.00162	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000363	0.0016	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—YAP1—ovarian cancer	0.00036	0.00159	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—SOD1—ovarian cancer	0.000358	0.00158	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—XIAP—ovarian cancer	0.000352	0.00155	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—SMARCA4—ovarian cancer	0.000344	0.00151	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.00034	0.0015	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—EREG—ovarian cancer	0.000335	0.00148	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PPP2R1A—ovarian cancer	0.000331	0.00146	CbGpPWpGaD
MACITENTAN—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	0.000331	0.00146	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—PIK3CD—ovarian cancer	0.00033	0.00145	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—VEGFA—ovarian cancer	0.000322	0.00142	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—IL6—ovarian cancer	0.000319	0.00141	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000316	0.0014	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PGR—ovarian cancer	0.000314	0.00139	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—ovarian cancer	0.000306	0.00135	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CXCL8—ovarian cancer	0.000304	0.00134	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—NME2—ovarian cancer	0.000299	0.00132	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000296	0.0013	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PARP1—ovarian cancer	0.000292	0.00129	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—IL2—ovarian cancer	0.000291	0.00128	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.00029	0.00128	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—PIK3CB—ovarian cancer	0.000287	0.00127	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—TP53—ovarian cancer	0.000283	0.00125	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—IL6ST—ovarian cancer	0.000279	0.00123	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CXCL8—ovarian cancer	0.000276	0.00122	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—NME2—ovarian cancer	0.000269	0.00118	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—PIK3CG—ovarian cancer	0.000268	0.00118	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	0.000265	0.00117	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—IL2—ovarian cancer	0.000264	0.00116	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TERT—ovarian cancer	0.000263	0.00116	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000261	0.00115	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—PIK3CD—ovarian cancer	0.00026	0.00115	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—IL6—ovarian cancer	0.000259	0.00114	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—SPARC—ovarian cancer	0.000254	0.00112	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000254	0.00112	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CAV1—ovarian cancer	0.000243	0.00107	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	0.000239	0.00105	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PPP2R1A—ovarian cancer	0.000237	0.00104	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—PIK3CD—ovarian cancer	0.000236	0.00104	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—ESR1—ovarian cancer	0.000234	0.00103	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IL6ST—ovarian cancer	0.000231	0.00102	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000228	0.00101	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000227	0.000999	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PIK3CG—ovarian cancer	0.000222	0.000977	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—APC—ovarian cancer	0.000222	0.000977	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—NRAS—ovarian cancer	0.000222	0.000977	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CXCL8—ovarian cancer	0.000218	0.00096	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—MAPK3—ovarian cancer	0.000212	0.000935	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	0.00021	0.000924	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—IL2—ovarian cancer	0.000208	0.000917	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000207	0.000913	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—IL6—ovarian cancer	0.000206	0.000909	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—PIK3CB—ovarian cancer	0.000206	0.000907	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—MAPK1—ovarian cancer	0.000202	0.00089	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—EGFR—ovarian cancer	0.000202	0.00089	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CXCL8—ovarian cancer	0.000198	0.000871	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PIK3CD—ovarian cancer	0.000195	0.000859	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000194	0.000854	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—PIK3CA—ovarian cancer	0.000193	0.000851	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CYTB—ovarian cancer	0.000193	0.00085	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—KRAS—ovarian cancer	0.000191	0.000841	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—IL2—ovarian cancer	0.000189	0.000833	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000189	0.000831	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TERT—ovarian cancer	0.000188	0.00083	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000187	0.000824	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000186	0.000819	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—SOD1—ovarian cancer	0.000185	0.000814	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—PPP2R1A—ovarian cancer	0.000184	0.00081	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	0.000183	0.000806	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—PIK3CA—ovarian cancer	0.000175	0.000772	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CAV1—ovarian cancer	0.000174	0.000767	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CYTB—ovarian cancer	0.000173	0.000763	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—ERBB2—ovarian cancer	0.000172	0.000758	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MTOR—ovarian cancer	0.00017	0.000748	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PIK3CB—ovarian cancer	0.00017	0.000748	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000169	0.000746	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—BRIP1—ovarian cancer	0.000169	0.000743	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PPP1CC—ovarian cancer	0.000169	0.000743	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	0.000168	0.00074	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—ESR1—ovarian cancer	0.000168	0.00074	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IL6ST—ovarian cancer	0.000165	0.000728	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CXCL8—ovarian cancer	0.000163	0.000719	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—HRAS—ovarian cancer	0.000162	0.000715	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—NME2—ovarian cancer	0.000162	0.000712	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CDKN1B—ovarian cancer	0.000159	0.000702	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PIK3CG—ovarian cancer	0.000159	0.000699	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—APC—ovarian cancer	0.000159	0.000699	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—NRAS—ovarian cancer	0.000159	0.000699	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—AKT1—ovarian cancer	0.000158	0.000695	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CASP3—ovarian cancer	0.000156	0.000688	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IL2—ovarian cancer	0.000156	0.000687	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—IL6—ovarian cancer	0.000155	0.000684	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CCND1—ovarian cancer	0.000152	0.00067	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—MAPK3—ovarian cancer	0.000152	0.00067	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PPP1CC—ovarian cancer	0.000151	0.000667	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—BRIP1—ovarian cancer	0.000151	0.000667	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CTNNB1—ovarian cancer	0.000151	0.000664	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000148	0.000651	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MMP9—ovarian cancer	0.000148	0.000651	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PTEN—ovarian cancer	0.000147	0.000647	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—MAPK1—ovarian cancer	0.000145	0.000637	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—EGFR—ovarian cancer	0.000144	0.000637	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—AKT1—ovarian cancer	0.000143	0.000631	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	0.000143	0.000629	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PIK3CD—ovarian cancer	0.000139	0.000615	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—PIK3CA—ovarian cancer	0.000138	0.000609	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—KRAS—ovarian cancer	0.000136	0.000602	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—CAV1—ovarian cancer	0.000135	0.000595	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	0.000135	0.000595	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—VEGFA—ovarian cancer	0.000133	0.000584	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—STAT3—ovarian cancer	0.000131	0.000578	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—NRAS—ovarian cancer	0.000131	0.000577	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	0.000128	0.000566	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—PIK3CA—ovarian cancer	0.000125	0.000553	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MAPK3—ovarian cancer	0.000125	0.000553	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—ERBB2—ovarian cancer	0.000123	0.000543	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—PIK3CG—ovarian cancer	0.000123	0.000542	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000123	0.000542	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MYC—ovarian cancer	0.000122	0.000537	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PIK3CB—ovarian cancer	0.000122	0.000536	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MTOR—ovarian cancer	0.000122	0.000536	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MAPK1—ovarian cancer	0.000119	0.000526	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—EGFR—ovarian cancer	0.000119	0.000526	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CXCL8—ovarian cancer	0.000117	0.000515	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—HRAS—ovarian cancer	0.000116	0.000511	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CDKN1B—ovarian cancer	0.000114	0.000503	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—YAP1—ovarian cancer	0.000113	0.000499	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—AKT1—ovarian cancer	0.000113	0.000497	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—KRAS—ovarian cancer	0.000113	0.000497	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000112	0.000493	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CASP3—ovarian cancer	0.000112	0.000493	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IL2—ovarian cancer	0.000112	0.000492	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	0.000111	0.000491	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—IL6—ovarian cancer	0.000111	0.000489	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.00011	0.000486	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CCND1—ovarian cancer	0.000109	0.00048	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—PIK3CD—ovarian cancer	0.000108	0.000476	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CTNNB1—ovarian cancer	0.000108	0.000475	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MMP9—ovarian cancer	0.000106	0.000466	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PTEN—ovarian cancer	0.000105	0.000463	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CYTB—ovarian cancer	0.000104	0.000459	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PIK3CA—ovarian cancer	0.000103	0.000456	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—AKT1—ovarian cancer	0.000102	0.000452	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—YAP1—ovarian cancer	0.000102	0.000448	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.0001	0.000443	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TP53—ovarian cancer	0.0001	0.000441	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.84e-05	0.000434	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—HRAS—ovarian cancer	9.58e-05	0.000422	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—VEGFA—ovarian cancer	9.48e-05	0.000418	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—PIK3CB—ovarian cancer	9.42e-05	0.000415	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—STAT3—ovarian cancer	9.39e-05	0.000414	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—NRAS—ovarian cancer	9.37e-05	0.000413	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—FASN—ovarian cancer	9.22e-05	0.000406	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IL6—ovarian cancer	9.16e-05	0.000404	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PPP1CC—ovarian cancer	9.1e-05	0.000401	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—BRIP1—ovarian cancer	9.1e-05	0.000401	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	9.1e-05	0.000401	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SLC5A5—ovarian cancer	9.07e-05	0.0004	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MAPK3—ovarian cancer	8.97e-05	0.000396	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.83e-05	0.000389	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SLC2A1—ovarian cancer	8.76e-05	0.000386	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MYC—ovarian cancer	8.73e-05	0.000385	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—IL2—ovarian cancer	8.65e-05	0.000381	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.58e-05	0.000378	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MAPK1—ovarian cancer	8.54e-05	0.000376	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—EGFR—ovarian cancer	8.53e-05	0.000376	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—AKT1—ovarian cancer	8.45e-05	0.000373	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CYP1B1—ovarian cancer	8.4e-05	0.00037	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—FASN—ovarian cancer	8.28e-05	0.000365	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SLC5A5—ovarian cancer	8.14e-05	0.000359	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—KRAS—ovarian cancer	8.06e-05	0.000355	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SLC2A1—ovarian cancer	7.86e-05	0.000347	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.7e-05	0.000339	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CYP1B1—ovarian cancer	7.54e-05	0.000332	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PPP2R1A—ovarian cancer	7.45e-05	0.000328	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.41e-05	0.000327	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PIK3CA—ovarian cancer	7.41e-05	0.000327	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—VEGFA—ovarian cancer	7.35e-05	0.000324	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—NRAS—ovarian cancer	7.26e-05	0.00032	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TP53—ovarian cancer	7.17e-05	0.000316	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—MAPK3—ovarian cancer	6.96e-05	0.000307	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ABCB1—ovarian cancer	6.92e-05	0.000305	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—HRAS—ovarian cancer	6.85e-05	0.000302	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—TYMS—ovarian cancer	6.79e-05	0.000299	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	6.69e-05	0.000295	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.65e-05	0.000293	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—MAPK1—ovarian cancer	6.62e-05	0.000292	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IL6—ovarian cancer	6.56e-05	0.000289	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—KRAS—ovarian cancer	6.25e-05	0.000276	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ABCB1—ovarian cancer	6.21e-05	0.000274	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—YAP1—ovarian cancer	6.11e-05	0.000269	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—TYMS—ovarian cancer	6.1e-05	0.000269	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—AKT1—ovarian cancer	6.05e-05	0.000267	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—PIK3CA—ovarian cancer	5.74e-05	0.000253	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—TP53—ovarian cancer	5.56e-05	0.000245	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CAV1—ovarian cancer	5.47e-05	0.000241	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—HRAS—ovarian cancer	5.31e-05	0.000234	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.23e-05	0.00023	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PIK3CG—ovarian cancer	4.98e-05	0.00022	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—FASN—ovarian cancer	4.98e-05	0.000219	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CAV1—ovarian cancer	4.91e-05	0.000217	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SLC5A5—ovarian cancer	4.9e-05	0.000216	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SLC2A1—ovarian cancer	4.73e-05	0.000208	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.69e-05	0.000207	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—AKT1—ovarian cancer	4.69e-05	0.000207	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CYP1B1—ovarian cancer	4.53e-05	0.0002	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PIK3CG—ovarian cancer	4.47e-05	0.000197	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PIK3CD—ovarian cancer	4.38e-05	0.000193	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	4.02e-05	0.000177	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PIK3CD—ovarian cancer	3.93e-05	0.000173	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PIK3CB—ovarian cancer	3.82e-05	0.000168	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ABCB1—ovarian cancer	3.73e-05	0.000165	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—TYMS—ovarian cancer	3.67e-05	0.000162	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PIK3CB—ovarian cancer	3.43e-05	0.000151	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PTEN—ovarian cancer	3.3e-05	0.000146	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PTEN—ovarian cancer	2.96e-05	0.000131	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CAV1—ovarian cancer	2.95e-05	0.00013	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.69e-05	0.000119	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.37e-05	0.000104	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PIK3CA—ovarian cancer	2.33e-05	0.000103	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PIK3CA—ovarian cancer	2.09e-05	9.21e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.06e-05	9.09e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—AKT1—ovarian cancer	1.9e-05	8.39e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PTEN—ovarian cancer	1.78e-05	7.85e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—AKT1—ovarian cancer	1.71e-05	7.53e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.26e-05	5.54e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—AKT1—ovarian cancer	1.03e-05	4.53e-05	CbGpPWpGaD
